Somaieh Ahmadian

Dr. Somaieh Ahmadian

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Toxicology Mechanisms and Methods
Verified
Journal Article
Closed access
YOYadollah Omidi
Yadollah Omidi
JBJaleh Barar
Jaleh Barar
HHHamid Reza Heidari
Hamid Reza Heidari
SASomaieh Ahmadian
Somaieh Ahmadian
HYHossein Ahmadpour Yazdi
Hossein Ahmadpour Yazdi
SASaghir Akhtar
Saghir Akhtar
Viral and nonviral vectors have been widely used in gene therapy as delivery reagents for nucleic acids. Toxicity with viral vectors has increasingly led to the search for suitable nonviral vectors, such as cationic lipids/polymers, as potentially safer alternatives. However, little is known about the genomic toxicity of these delivery systems in target cells/tissues. In the current investigation, we report on the toxicogenomics and genotoxicity of cationic lipid Oligofectamine (OF) nanosystems in human alveolar epithelial A549 cells. To investigate the nature and the ontology of the gene expression changes in A549 cells upon treatment with OF nanoliposomes, microarray gene expression profiling methodology was utilized. For microarray analysis, cyanine (Cy3/Cy5)-labeled cDNA samples from treated and untreated cells were hybridized on target arrays housing 200 genes. Both OF and OF-DNA lipoplex induced significant gene expression changes belonging to the different genomic ontologies such as cell defense and apoptosis pathways. Flow cytometry analyses revealed induction of apoptosis in A549 cells treated with these nanosystems that is likely due to interactions and/or deterioration of the cell membranes. However, no DNA damage was detected by the Comet assay. These data suggest that cationic nanoliposomes in the absence of direct DNA damage elicit multiple gene expression changes in A549 cells that may compromise the main goals of gene medicine where only therapy-defined gene changes are required.

3 April 2009 in Journal of Visualized Experiments
Verified
Journal Article
Open access
PDF file
SASomaieh Ahmadian
Somaieh Ahmadian
JBJaleh Barar
Jaleh Barar
Amirata Saei DibavarAmirata Saei Dibavar
Amirata Saei Dibavar
MFMohammad Amin Abolghassemi Fakhree
Mohammad Amin Abolghassemi Fakhree
YOYadollah Omidi
Yadollah Omidi
The MTT assay is an easy and reproducible colorimetric assay for evaluation of cell viability based on reduction of yellow MTT and...

25 October 2012 in Journal of Chemical & Engineering Data
Verified
Journal Article
Closed access
MFMohammad A. A. Fakhree
Mohammad A. A. Fakhree
SASomaieh Ahmadian
Somaieh Ahmadian
VPVahid Panahi-Azar
Vahid Panahi-Azar
WAWilliam E. Acree
William E. Acree
Abolghasem JouybanAbolghasem Jouyban
Abolghasem Jouyban

2 June 2011 in Journal of Chemical & Engineering Data
Verified
Journal Article
Closed access
SASomaieh Ahmadian
Somaieh Ahmadian
VPVahid Panahi-Azar
Vahid Panahi-Azar
MFMohammad A. A. Fakhree
Mohammad A. A. Fakhree
WAWilliam E. Acree
William E. Acree
Abolghasem JouybanAbolghasem Jouyban
Abolghasem Jouyban

21 January 2008 in Cell Biochemistry and Function
Verified
Journal Article
Closed access
PDF file
YOYadollah Omidi
Yadollah Omidi
JBJaleh Barar
Jaleh Barar
SASomaieh Ahmadian
Somaieh Ahmadian
HHHamid Reza Heidari
Hamid Reza Heidari
MGMark Gumbleton
Mark Gumbleton

1 September 2012 in Fluid Phase Equilibria
Verified
Journal Article
Closed access
VPVahid Panahi-Azar
Vahid Panahi-Azar
SASomaieh Ahmadian
Somaieh Ahmadian
Fleming MartinezFleming Martinez
Fleming Martinez
WAWilliam E. Acree
William E. Acree
Abolghasem JouybanAbolghasem Jouyban
Abolghasem Jouyban